Journey Medical Corp
corporate_fare Company Profile
Journey Medical Corp (NASDAQ:DERM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for DERM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for DERM spans 10-Q, 8-K, 10-K, 424B3.
Recent high-impact activity:
- Journey Medical 10-Q: Q3 Revenue $19.0M, Going-Concern Doubt Persists
- Journey Medical Q3 Revenue Rises 8% as Emrosi Sales Jump 84%
- Journey Medical Q2 Revenue Up 23%, But Going Concern Warning Persists
- Journey Medical Q2 Revenue Jumps 23%, Loss Narrows to $0.3M
- Journey Medical Q2 Revenue Up 23% to $18.5M, Loss Narrows to $0.3M
Financial Snapshot
Short Interest & Short Volume
15.07 days to coverFINRA reported short interest of 3,085,027 shares in DERM as of the October 30, 2026 settlement, a 3.3% increase from the prior period — about 15.1 days to cover at its recent average daily volume. On November 20, 2026, 37.2% of DERM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.